Unique Ingredient Identifier H3R47K3TBD is listed as a ingredient substance
| RN | 3844-45-9 |
| NCIT | C71674 |
| RXCUI | 1310605 |
UNII H3R47K3TBD FD&C BLUE NO. 1 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| DENTAL | PASTE | NA |
| DENTAL | SOLUTION | 0.01 % |
| ORAL | BAR, CHEWABLE | NA |
| ORAL | CAPSULE | 4.78 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | 0.13 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELAT | 0.2 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 0.034 MG |
| ORAL | CAPSULE, DELAYED ACTION | 0.5 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 0.035 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | NA |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.78 MG |
| ORAL | CAPSULE, HARD GELATIN | 3.71 MG |
| ORAL | CAPSULE, SOFT GELATIN | 0.04 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 0.024 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 0.9 MG |
| ORAL | CONCENTRATE | NA |
| ORAL | FILM, SOLUBLE | 0.036 MG |
| ORAL | LIQUID | 0.016 MG/15ML |
| ORAL | POWDER | NA |
| ORAL | POWDER, FOR ORAL SOLUTION | NA |
| ORAL | POWDER, FOR SUSPENSION | 1 MG/5ML |
| ORAL | SOLUTION | 1.13 MG/15ML |
| ORAL | SOLUTION, ELIXIR | 0.023 MG/5ML |
| ORAL | SUSPENSION | 0.075 MG/5ML |
| ORAL | SUSPENSION, LIQUID | 0.045 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | NA |
| ORAL | SYRUP | 0.043 MG/5ML |
| ORAL | TABLET | 20 MG |
| ORAL | TABLET, COATED | 0.52 MG |
| ORAL | TABLET, DELAYED ACTION | 0.037 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | TABLET, EXTENDED RELEASE | 1.36 MG |
| ORAL | TABLET, FILM COATED | 0.16 MG |
| ORAL | TABLET, SUSTAINED ACTION | NA |
| ORAL | TABLET, SUSTAINED ACTION, COATED | NA |
| RECTAL | SOLUTION | 0.005 % |
| SUBLINGUAL | FILM | QS |
| SUBLINGUAL | FILM | PNG |
| SUBLINGUAL | TABLET | 0.03 MG |
| TOPICAL | LOTION | NA |
| TOPICAL | SHAMPOO | 0.004 %W/W |
| TOPICAL | SHAMPOO, SUSPENSION | NA |
| TOPICAL | SPONGE | 0.005 %W/W |
| TOPICAL | SWAB | NA |